Clinical Trial Update: Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and Back [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating topical tazarotene for basal cell carcinoma and basal cell nevus syndrome on the chest and back has completed and posted resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma
• Basal Cell Nevus Syndrome

Drugs mentioned

• TAZAROTENE (TAZAROTENE)

Snippet

Sponsor: UCSF Benioff Children's Hospital Oakland | Conditions: Skin Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2016-02-11